5 Best Stocks To Buy For A Stock Market Game

3. Compass Therapeutics Inc. (NASDAQ:CMPX)

One-Year Return as of April 25: 79.87%

Number of Hedge Fund Holders: 20

Compass Therapeutics Inc. (NASDAQ:CMPX) is a biotechnology company focused on oncology. It is based in Boston, Massachusetts.

Robert Driscoll, an analyst at Wedbush, holds an Outperform rating on Compass Therapeutics Inc. (NASDAQ:CMPX) shares as of April 20.

The average price target placed on shares of Compass Therapeutics Inc. (NASDAQ:CMPX) by Wall Street analysts is $9.2, while the shares were trading at $2.67 on April 25. This gives them an upside potential of 243.93%.

A total of 20 hedge funds were long Compass Therapeutics Inc. (NASDAQ:CMPX) in the fourth quarter, with a total stake value of $224 million.

Follow Compass Therapeutics Inc.